More than Just a Life Support,
We Restore What Life is Meant To Be.
We are dedicated to addressing the unmet health care needs of patients suffering from cardiovascular diseases.
More than Just a Life Support,
We Restore What Life is Meant To Be.
We are dedicated to addressing the unmet health care needs of patients suffering from cardiovascular diseases.
ANIVIA SG1000 Pump Console
ANIVIA SG1000 Pump Console
A versatile and flexible cardiopulmonary bypass speed control solution for extracorporeal blood circuits.
The SG1000 Pump Console is a key component of the Anivia System, designed to drive disposable centrifugal pump heads in extracorporeal blood circuits. Its open-system architecture allows for interoperability with various disposable brands, offering flexible configurations to meet diverse clinical demands.
Follow a manual added link
APMTD won the golden prize in H. Spectrum Project Phoenix
October 18, 2023
APMTD won the golden prize at H. Spectrum Demo Day and was awarded an MOU for business collaboration with Foxconn Technology Co. Ltd. H. Spectrum, a leading health tech international accelerator in APAC, hosts the Golden Phoenix competition every year. In 2023, 183 companies registered for the Project Phoenix competition, and 13 companies advanced to the final round. APMTD secured the golden prize in the international group.
Follow a manual added link
Anivia Attracts Spotlight at the 42nd Cardiothoracic Symposium
September 13-16, 2023
APMTD proudly showcased our innovations at the 42nd Cardiothoracic Surgery Symposium in San Diego, USA. Spanning four days, this prestigious international conference attracts perfusionists from around the globe. We were thrilled by the enthusiastic reception from attendees and have identified numerous potential clients.
Follow a manual added link
APMTD Unveils Anivia Console at Sanibel Symposium 2023
May 10-13, 2023
APMTD Unveils Anivia Console at Sanibel Symposium 2023 held in Bonita Springs, Florida from May 10-13, 2023. The Anivia Console is the first “open-system” extracorporeal platform developed to meet the growing clinical demands for flexibility in the medical field. The system was cleared by the FDA in February 2023.
For more information, please contact us.